301 related articles for article (PubMed ID: 24788066)
21. Bimatoprost versus travoprost in an Egyptian population: a hospital-based prospective, randomized study.
Macky TA
J Ocul Pharmacol Ther; 2010 Dec; 26(6):605-10. PubMed ID: 21034177
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of travoprost, latanoprost and bimatoprost on ocular circulation: a 6-month clinical trial.
Koz OG; Ozsoy A; Yarangumeli A; Kose SK; Kural G
Acta Ophthalmol Scand; 2007 Dec; 85(8):838-43. PubMed ID: 17680841
[TBL] [Abstract][Full Text] [Related]
23. A comparative study of bimatoprost and travoprost: effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients.
Alagoz G; Gürel K; Bayer A; Serin D; Celebi S; Kukner S
Ophthalmologica; 2008; 222(2):88-95. PubMed ID: 18303228
[TBL] [Abstract][Full Text] [Related]
24. A multicentre evaluation of the effect of patient education on acceptance of hyperaemia associated with bimatoprost therapy for glaucoma or ocular hypertension.
Trattler W; Noecker RJ; Earl ML
Adv Ther; 2008 Mar; 25(3):179-89. PubMed ID: 18351298
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.
Chen MJ; Chen YC; Chou CK; Hsu WM
J Ocul Pharmacol Ther; 2007 Dec; 23(6):559-66. PubMed ID: 18001247
[TBL] [Abstract][Full Text] [Related]
26. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
Cantor LB; WuDunn D; Cortes A; Hoop J; Knotts S
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S12-8. PubMed ID: 15016557
[TBL] [Abstract][Full Text] [Related]
27. Diurnal intraocular pressure with bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in healthy subjects.
Shim SH; Kim JM; Choi CY; Kim CY
Korean J Ophthalmol; 2014 Feb; 28(1):39-48. PubMed ID: 24505200
[TBL] [Abstract][Full Text] [Related]
28. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
[TBL] [Abstract][Full Text] [Related]
29. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.
Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
Br J Ophthalmol; 2008 Sep; 92(9):1227-31. PubMed ID: 18586898
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: a preliminary study.
Vyas P; Naik U; Gangaiah JB
Indian J Ophthalmol; 2011; 59(1):13-6. PubMed ID: 21157066
[TBL] [Abstract][Full Text] [Related]
31. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.
Brandt JD; VanDenburgh AM; Chen K; Whitcup SM;
Ophthalmology; 2001 Jun; 108(6):1023-31; discussion 1032. PubMed ID: 11382623
[TBL] [Abstract][Full Text] [Related]
32. [Monotherapy with lipid structural derivatives in glaucoma].
Călugăru D; Călugăru M
Oftalmologia; 2010; 54(2):30-43. PubMed ID: 20827909
[TBL] [Abstract][Full Text] [Related]
33. Bimatoprost loaded nanovesicular long-acting sub-conjunctival in-situ gelling implant: In vitro and in vivo evaluation.
Yadav M; Guzman-Aranguez A; Perez de Lara MJ; Singh M; Singh J; Kaur IP
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109730. PubMed ID: 31349399
[TBL] [Abstract][Full Text] [Related]
34. Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patients.
Figus M; Nardi M; Piaggi P; Sartini M; Guidi G; Martini L; Lazzeri S
Eye (Lond); 2014 Apr; 28(4):422-9. PubMed ID: 24434659
[TBL] [Abstract][Full Text] [Related]
35. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.
Sherwood M; Brandt J;
Surv Ophthalmol; 2001 May; 45 Suppl 4():S361-8. PubMed ID: 11434939
[TBL] [Abstract][Full Text] [Related]
36. Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
Curran MP
Drugs Aging; 2009; 26(12):1049-71. PubMed ID: 19929032
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of intraocular pressure lowering efficacy of bimatoprost / timolol fixed combination and other glaucoma medications in the treatment of glaucoma].
Skorkovská K
Cesk Slov Oftalmol; 2008 Jul; 64(4):144-8. PubMed ID: 18780653
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.
Sato S; Hirooka K; Baba T; Mizote M; Fujimura T; Tenkumo K; Ueda H; Shiraga F
J Ocul Pharmacol Ther; 2011 Oct; 27(5):499-502. PubMed ID: 21790301
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the effect of bimatoprost/timolol fixed combination on ocular blood flow in patients with ocular hypertension using colour Doppler imaging. Preliminary study].
García-Pérez JL; Puerto-Hernández B; Rebolleda Fernández G; Muñoz-Negrete FJ; González-Gordaliza C
Arch Soc Esp Oftalmol; 2010 Apr; 85(4):131-7. PubMed ID: 20858400
[TBL] [Abstract][Full Text] [Related]
40. [Bimatoprost therapy in glaucoma].
Călugăru D; Călugăru M
Oftalmologia; 2009; 53(3):34-45. PubMed ID: 19899545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
